LRG1: an emerging player in disease pathogenesis

Abstract excerpt

Abstract The secreted glycoprotein leucine-rich α-2 glycoprotein 1 (LRG1) was first described as a key player in pathogenic ocular neovascularization almost a decade ago. Since then, an increasing number of publications have reported the involvement of LRG1 in multiple human conditions including cancer, diabetes, cardiovascular disease, neurological disease, and inflammatory disorders. The purpose of this review...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clusterin in disease pathology
• Share to Lipid metabolism and disorders
• Share to Sepsis Diagnosis and Treatment